News » Archives » September 2018

Models for Accelerating Academic Rare Disease Research and Innovation: A Working Session Hosted by Notre Dame

Author: College of Science

20181011 200945

An interactive working session hosted by Notre Dame to explore how universities can accelerate rare disease research and discovery through innovation, entrepreneurship and cross-sector partnerships.

Co-chairs: 
John Crowley, Chairman and CEO of Amicus Therapeutics and Founding Board Member of Global Genes

Read More about Models for Accelerating Academic Rare Disease Research and Innovation: A Working Session Hosted by Notre Dame